According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
According to a newly published market research report by 24LifeSciences, global head lice infestation treatment market was valued at USD 548.8 million in 2023 and is projected to reach USD 723.7 million by 2030, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2024–2030.
Head lice (Pediculus humanus capitis) are parasitic insects that infest human...
The Peptide CDMO Pharmaceutical Market research report has been crafted with the most advanced and best tools to collect, record, estimate, and analyze market data. The report also sheds light on the market overview in its entirety touching diverse aspects like product definition, prevailing vendor landscape, and market segmentation. Through the comprehensive and systematic market research...
Pharmerging Industry Outlook:
Straits Research has introduced a detailed analytical study on the Pharmerging Market, offering insights into market valuation, segmentation framework, and long-term growth trajectory. The publication delivers a structured overview of market drivers, constraints, technological advancements, and strategic developments shaping the industry. In addition, it...
According to a newly published market research report by 24LifeSciences, the global recombinant human erythropoietin injection market was valued at USD 7.6 billion in 2024 and is projected to reach USD 10.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025–2032.
Recombinant human erythropoietin (rhEPO) injection is a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt